headband-icade

Regulated information

en
fr
logo-icade
en
fr

Home

Investisseurs

Information réglementée

The information presented in this section concerns both Icade Santé (healthcare assets held in France) and Icade Healthcare Europe (healthcare assets held internationally).

Filter by

Results notice EUR 500M 0.875 per cent Notes due 2029

27 Jul 2021

16:15

PDF - 298 Kb

Approbation of the change of Icade Santé corporate form and other amendments to the by-laws

27 Jul 2021

16:15

PDF - 671 Kb

Icade Santé : half-year results 2021

26 Jul 2021

07:30

PDF - 684 Kb

Condensed consolidated financial statements as of June 30, 2021

26 Jul 2021

07:30

PDF - 1,3 Mb

Consultation of the noteholders in the context of the contemplated initial public offering of Icade Santé

9 Jul 2021

08:45

PDF - 672 Kb

Report of the shareholders

9 Jul 2021

08:45

PDF - 381 Kb

Notice of meeting of noteholders MEUR 500 0.875 per cent Notes due 2029

9 Jul 2021

08:45

PDF - 547 Kb

Icade Santé acquires a PAC facility from Orpea for €28M

1 Jul 2021

18:00

PDF - 617 Kb

Icade Santé acquires another four facilities in France

23 Jun 2021

18:00

PDF - 650 Kb

Handover of four facilities for a total investment of €76M, liquidity event : IPO currently the preferred option, a CFO appointed

7 Jun 2021

07:30

PDF - 770 Kb

Consolidated financial statements 2020

22 Feb 2021

07:30

PDF - 1,4 Mb

Press Release - 2020 Full Year Results

22 Feb 2021

07:30

PDF - 706 Kb

Icade's Healthcare Property portfolio continues to grow with €163M in new investments in Italy and France

21 Dec 2020

07:30

PDF - 770 Kb

Icade Santé acquires the real estate of the Navarre polyclinic

5 Nov 2020

17:45

PDF - 730 Kb

Icade Santé - Social Bond Final Prospectus

16 Sep 2020

11:00

PDF - 3,4 Mb

Icade Santé, Places that care for people

Contact us